To determine whether the weight loss sensitization effect of GIPR-antag extended to Cagri, we transferred WT mice to an HFD and treated with VEH, Cagri, GIPR-antag and the combination (Cagri + antag)
Concentraciones de referencia : Vial 5 mg: 1 mL BAC 5,000 g/mL (500 g = 0.1 mL = 10 UI) 2 mL BAC 2,500 g/mL (250 g = 0.1 mL = 10 UI) Vial 10 mg: 2 mL BAC 5,000 g/mL (500 g = 0.1 mL = 10 UI) 5 mL BAC 2,000 g/mL (200 g = 0.1 mL = 10 UI) Vial 20 mg: 4 mL BAC 5,000 g/mL 5 mL BAC 4,000 g/mL Jeringa : insulina U-100 de 0.30.5 mL, aguja 2931G 8 mm para subcutnea
Glutathione/glutathione disulfide (GSH/GSSG) ratio and Nicotinamide adenine dinucleotide phosphate NADPH/NADP+ ratio were measured using GSH/GSSG Assay Kit (S0053, Beyotime) and NADP/NADPH Quantification Kit (S0179, Beyotime) respectively
Enhanced Fat Burning : Supports fat metabolism and weight loss efforts